1 - 3 / 3 1 |
1. Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy Sanja Nabergoj, Irena Mlinarič-Raščan, Žiga Jakopin, 2019, review article Keywords: adjuvants, cancer immunotherapy, immunotherapeutics, NOD1 agonists, NOD1 antagonists, NOD2 agonists, NOD2 antagonists |
2. Physical models of immunotherapy Damijan Valentinuzzi, 2020, doctoral dissertation Keywords: cancer, modelling, immunotherapy, anti-PD-1, iRADIOMICS, non-small-cell lung cancer, MHC class I |
3. Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer Veronika Pelicon, Tanja Čufer, Lea Knez, 2023, original scientific article Keywords: non-small cell lung cancer, immunotherapy, chemo-immunotherapy, realworld outcomes, first line |